GLP-1 Receptor Agonists in Anesthesia: Bridging Delayed Gastric Emptying, Aspiration Risk, and Practical Management
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and the dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist tirzepatide are now prescribed widely for type 2 diabetes and obesity. Because these drugs slow gastric emptying, they have been linked to retained gastric contents despite fasting and, in case reports, to pulmonary aspiration. Early guidance advised holding the drugs before elective procedures, whereas later consensus statements advised continuing them with mitigation. This narrative review addresses how much, and for how long, these agents delay gastric emptying; whether they increase residual gastric content and pulmonary aspiration; and what the anesthesiologist should do. Physiologic studies show a measurable delay whose attenuation with prolonged treatment is disputed. Most observational studies and all four meta-analyses that pooled residual content found more residual gastric content in users. Most large cohort studies and meta-analyses did not find an increase in pulmonary aspiration; one endoscopy cohort and one elective-surgery study, both known here only as reported in other sources, did, and the certainty of the evidence is low. A randomized trial of holding one dose versus continuing, an interim analysis stopped early in sedated endoscopy, found less clinically significant residual gastric volume with holding, but it was not powered to detect aspiration. We close with a practical framework for identifying patients, stratifying risk, deciding about the drug, diet, assessing gastric content and planning the airway; it rests largely on consensus statements and expert opinion, because no trial has tested a fasting or airway strategy against aspiration outcomes.
Authors
- Salman Mashary Alharbi (ORCID: https://orcid.org/0009-0007-8254-3429)
- Abdulrahman Fahad Almusallam (ORCID: https://orcid.org/0009-0000-4653-6773)
Institutions
- King Saud University (SA)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-22
- DOI
- https://doi.org/10.5281/zenodo.24430848
- Primary Topic
- Diabetes Treatment and Management
- Type
- preprint